These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37074491)

  • 1. Keverprazan Hydrochloride: First Approval.
    Kang C
    Drugs; 2023 May; 83(7):639-643. PubMed ID: 37074491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vonoprazan: first global approval.
    Garnock-Jones KP
    Drugs; 2015 Mar; 75(4):439-43. PubMed ID: 25744862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of keverprazan, a novel potassium-competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double-blind multicentre study.
    Chen S; Liu D; Chen H; Liao A; Li F; Liu C; Li X; Li S; Zhang Y; Wang Y; Xia M; Guo Q; Miao X; Wen Z; Xu M; Yin H; Chen H; Chen M; Xiao Y
    Aliment Pharmacol Ther; 2022 Jun; 55(12):1524-1533. PubMed ID: 35505467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of keverprazan for duodenal ulcer: A phase II randomized, double-blind, parallel-controlled trial.
    Tan ND; Liu XW; Liu CX; Li SB; Chen HH; Li X; Wu H; Liao AJ; Zhen YB; Shen PZ; Huo LJ; Liu HL; Shi RH; Zhang BQ; Zhang ZY; Wang JN; Zhan Q; Deng H; Shu X; Tuo BG; Wang QZ; Du SY; Qi LZ; Zhang GX; Peng Q; Wang BM; Ye B; Chen MH; Xiao YL
    J Gastroenterol Hepatol; 2022 Nov; 37(11):2060-2066. PubMed ID: 36068945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori-induced duodenal ulcer frequently coincides with gastro-oesophageal reflux disease.
    Mc Namara D; Buckley M; O'Morain C
    Dig Liver Dis; 2002 Aug; 34(8):542-6. PubMed ID: 12502209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse time trends of peptic ulcer and reflux esophagitis show significant association with reduced prevalence of
    Yamamichi N; Yamaji Y; Shimamoto T; Takahashi Y; Majima K; Wada R; Mitsushima T; Koike K
    Ann Med; 2020 Dec; 52(8):506-514. PubMed ID: 32536216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No protective role of Helicobacter pylori in the pathogenesis of reflux esophagitis in patients with duodenal or benign gastric ulcer in Korea.
    Kim N; Lim SH; Lee KH
    Dig Dis Sci; 2001 Dec; 46(12):2724-32. PubMed ID: 11768266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.
    Barradell LB; McTavish D
    Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients: unchanged frequency of erosive oesophagitis and decreased prevalence of non-erosive gastro-oesophageal reflux disease.
    Kupcinskas L; Jonaitis L; Kiudelis G
    Eur J Gastroenterol Hepatol; 2004 Apr; 16(4):369-74. PubMed ID: 15028968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease.
    Ishiki K; Mizuno M; Take S; Nagahara Y; Yoshida T; Yamamoto K; Okada H; Yokota K; Oguma K; Shiratori Y
    Clin Gastroenterol Hepatol; 2004 Jun; 2(6):474-9. PubMed ID: 15181615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keverprazan, a novel potassium-competitive acid blocker: Single ascending dose safety, tolerability, pharmacokinetics, pharmacodynamics and food effect in healthy subjects.
    Zhou S; Xie L; Zhou C; Zhao Y; Wang L; Ding S; Chen J; Zhu B; Su M; Shao F
    Eur J Pharm Sci; 2023 Nov; 190():106578. PubMed ID: 37666458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis.
    Labenz J; Blum AL; Bayerdörffer E; Meining A; Stolte M; Börsch G
    Gastroenterology; 1997 May; 112(5):1442-7. PubMed ID: 9136820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori.
    Tsukada K; Miyazaki T; Katoh H; Fukuchi M; Fukai Y; Kimura H; Sohda M; Yamada S; Toda N; Motojima T; Kuwano H
    Eur J Gastroenterol Hepatol; 2005 Oct; 17(10):1025-8. PubMed ID: 16148546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole: implications for therapy of peptic ulcer and reflux oesophagitis.
    Bium AL
    Digestion; 1989; 44 Suppl 1():87-91. PubMed ID: 2691314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus.
    Newton M; Bryan R; Burnham WR; Kamm MA
    Gut; 1997 Jan; 40(1):9-13. PubMed ID: 9155568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradigm shift: duodenal ulcer to reflux esophagitis and its relation to the longitudinal prevalence of H. pylori.
    Desai HG
    Trop Gastroenterol; 2009; 30(3):121-4. PubMed ID: 20306739
    [No Abstract]   [Full Text] [Related]  

  • 17. Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis.
    Raghunath AS; Hungin AP; Wooff D; Childs S
    Aliment Pharmacol Ther; 2004 Oct; 20(7):733-44. PubMed ID: 15379833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and gastro-oesophageal reflux disease: association and clinical implications. To treat or not to treat with anti-H. pylori therapy?
    Loffeld RJ; van der Hulst RW
    Scand J Gastroenterol Suppl; 2002; (236):15-8. PubMed ID: 12408498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of reflux oesophagitis after cure of Helicobacter pylori in a Japanese population.
    Murai T; Miwa H; Ohkura R; Iwazaki R; Nagahara A; Sato K; Yamada T; Ota K; Tanaka H; Kawabe M; Minowa T; Takei Y; Miyazaki A; Sato N
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():161-5. PubMed ID: 10807418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflux esophagitis and H. pylori.
    Bercík P; Verdú E; Armstrong D
    Gastroenterology; 1997 Dec; 113(6):2020-1. PubMed ID: 9394749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.